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Whereas members of the Navajo Nation are at high risk for
diabetes mellitus, there are no recent published estimates of
the burden of end-stage renal disease (ESRD), an important
sequela of diabetes, on the Navajo Nation, a 16 million acre
area in Arizona, New Mexico, and Utah with more than
200 000 tribal members. We used data from the US Renal
Data System to estimate the prevalence and incidence of
ESRD among Native American adults (X18 years) living on
the Navajo Nation. For comparison, we estimated the
prevalence and incidence of ESRD among all adults in the US,
all Native American adults in the US, and Native American
adults living in Arizona, New Mexico, Utah, and Colorado
excluding those living on the Navajo Nation. The age-
adjusted prevalence of ESRD in the Native American adults
on the Navajo Nation was 0.63%, which was higher than in
the US adults (0.19%, Po0.0001) and among the Native
American adults in the US (0.36%, Po0.0001), but lower than
among the other Native American adults in the Southwest
(0.89%, Po0.0001). The age-adjusted incidence of ESRD in
the Native American adults on the Navajo Nation was 0.11%,
which was also higher than in the US adults (0.045%,
Po0.0001) and among the Native American adults in the US
(0.073%, Po0.0009), but lower than among the other Native
American adults in the Southwest (0.17%, Po0.0003). The
reasons behind these disparities merit further study.
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Previous research has demonstrated considerable health
disparities between members of the Navajo Nation and the
general US population.1–3 For example, it is well established
that the rates of diabetes mellitus type II are greatly elevated
among the Navajo.4–6 In this study, we estimate the
prevalence and incidence of end-stage renal disease (ESRD),
an important sequela of diabetes, on the Navajo Nation.
Studies have shown that the rates of ESRD are elevated
among Native Americans in the US, particularly those living
in the Southwest. The age-adjusted prevalence of ESRD
among Native Americans in the US is almost twice that of the
general US population, whereas the age-adjusted incidence
among Native Americans in the US is one and a half times
that in the general US population.7 The age-adjusted
incidence of ESRD associated with diabetes among Southwest
Native Americans is almost six times that in the general US
population.7,8
Researchers have also looked at the rates of kidney disease
among the Zuni and Pima American Indian communities,
which neighbor the Navajo Nation. The age- and gender-
adjusted prevalence of ESRD among Zuni adults and
children, who live predominantly on the Zuni Pueblo in
southern New Mexico, is 1.7%, almost nine times that in the
general US population.9,10 Pima Indians, who live predomi-
nantly on the Gila River and Salt River Pima-Maricopa
Indian Communities in Arizona, also are known to have
greatly increased rates of kidney disease relative to the general
US population.11,12
One study from 1971 to 1985 found that the crude
prevalence of ESRD among the Navajo was three times that
among Caucasians in the US, whereas the crude incidence
was twice that among Caucasians.13 These authors calculated
a crude prevalence among Navajos of 0.070% and a crude
incidence of 0.018% in 1985. We were unable to find any
more recent studies of the burden of ESRD among Navajos.
Therefore, we sought to estimate the prevalence and
incidence of ESRD in this high-risk population. We
hypothesized that the prevalence and incidence of ESRD
among Native Americans living on the Navajo Nation would
be elevated relative to those in the general US population and
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the entire Native American population in the US but similar
to those among other Native Americans of the Southwest.
RESULTS
The age-adjusted prevalence of ESRD in Native American
adults on the Navajo Nation was approximately 3.2-fold
higher than in the general US adult population (Po0.0001)
and 1.8-fold higher than among Native American adults in
the US (Po0.0001), but 29% lower than among other Native
American adults living in the Southwest (Po0.0001) (see
Table 1). The age-adjusted prevalence of ESRD on the Navajo
Nation associated with diabetes was approximately 6.2-fold
higher than in the general US population (Po0.0001) and
1.7-fold higher than among Native Americans in the US
(Po0.0001), but 41% lower than among other Native
Americans living in the Southwest (Po0.0001). The age-
adjusted prevalence of ESRD not associated with diabetes on
the Navajo Nation was approximately 1.8-fold higher than in
both the general US population and among Native Amer-
icans in the US (Po0.0001), and 1.3-fold higher than among
other Native Americans living in the Southwest (Po0.006).
The age-adjusted incidence of ESRD in Native American
adults on the Navajo Nation was approximately 2.4-fold
higher than in the general US population (Po0.0001) and
1.5-fold higher than among Native American adults in the US
(Po0.0009), but 35% lower than among other Native
American adults living in the Southwest (Po0.0003) (see
Table 2). The age-adjusted incidence of ESRD on the Navajo
Nation associated with diabetes was approximately 4.5-fold
higher than in the general US population (Po0.0001) and
1.6-fold higher than among Native Americans in the US
(Po0.0005), but 36% lower than among other Native
Americans living in the Southwest (Po0.0004). The age-
adjusted incidence of ESRD on the Navajo Nation not
associated with diabetes was not significantly different from
that in the general US population (0.019 vs 0.025%,
Po0.20), among Native Americans in the US (0.019 vs
0.018%, Po0.75), or among other Native Americans living in
the Southwest (0.019 vs 0.025%, Po0.33).
Table 3 shows the incidence of ESRD stratified by age.
ESRD rates among adults under 45 years of age on the Navajo
Nation were elevated compared with adults under 45 years of
age in the general US population (0.018 vs 0.012%, Po0.19),
but this difference did not reach statistical significance. The
rates were significantly elevated in adults 45 years and older
compared with adults 45 years and older in the general US
population (0.20 vs 0.081%, Po0.0001), and this difference
was more pronounced than that in adults under 45. ESRD
rates among adults under 45 years of age on the Navajo
Nation were not significantly different from those in Native
American adults in the US under age 45 (0.018 vs 0.017%,
Po0.83); however, the rates were significantly elevated in
Table 1 | 2001 crude and age-adjusted prevalence of ESRD among four groups X18 years of age: Native Americans on the
Navajo Nation, the General US Population, Native Americans in the US, and Native Americans in the Southwest excluding
























Native Americans on the Navajo Nation 636 130 907 0.63% (0.49%) 0.43% (0.31%) 0.21% (0.17%) 0.54% (0.41%)
General US population 400 605 212 673 000 0.19% (0.19%) 0.069% (0.069%) 0.12% (0.12%) 0.14% (0.14%)
All Native Americans in the US 5556 2 023 000 0.36% (0.27%) 0.24% (0.17%) 0.12% (0.10%) 0.29% (0.21%)
Native Americans living in AZ, NM, CO, and UT
(excluding those on the Navajo Nation)
1481 250 820 0.89% (0.59%) 0.73% (0.46%) 0.16% (0.13%) 0.79% (0.52%)
ESRD, end-stage renal disease.
Table 2 | 2001 crude and age-adjusted incidence of ESRD among four groups X18 years of age: Native Americans on the
Navajo Nation, the General US Population, Native Americans in the US, and Native Americans in the Southwest excluding
























Native Americans on the Navajo Nation 109 130 907 0.11% (0.083%) 0.090% (0.066%) 0.019% (0.018%) 0.11% (0.083%)
General US population 93 886 212 673 000 0.045% (0.44%) 0.020% (0.020%) 0.025% (0.024%) 0.044% (0.043%)
All Native Americans in the US 1108 2 023 000 0.073% (0.055%) 0.055% (0.041%) 0.018% (0.014%) 0.072% (0.054%)
Native Americans Living in AZ, NM, CO, and UT
(excluding those on the Navajo Nation)
283 250 820 0.17% (0.11%) 0.14% (0.092%) 0.025% (0.021%) 0.16% (0.11%)
ESRD, end-stage renal disease.
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adults 45 years and older (0.20 vs 0.12%, Po0.0002). ESRD
rates among adults on the Navajo Nation were lower than
those in other Native American adults of the Southwest in
both adults under 45 years (0.018 vs 0.043%, Po0.0002) as
well as adults over 45 years (0.20 vs 0.27%, Po0.01);
however, the difference was less pronounced in adults over 45
years.
DISCUSSION
We found that the prevalence and incidence of ESRD among
adults on the Navajo Nation are considerably higher than
those in both the general US adult population and among all
Native American adults in the US. The prevalence and
incidence of ESRD are lower than those among other Native
American adults of the Southwest, however.
Both the prevalence and incidence of ESRD on the Navajo
Nation were higher in our study than in the study by Megill
et al.13 from 1985. In the earlier study, the crude prevalence
and incidence of ESRD among Navajos of all ages were 0.070
and 0.018%, respectively, compared with 0.49 and 0.083% in
adults in our study. It is difficult to draw conclusions about
temporal trends in ESRD burden on the Navajo Nation from
these studies for two reasons. First, we only included adults
in our analysis, whereas Megill et al.13 included adults and
children. Second, the two studies used somewhat different
data sources. (As we have performed in this study, Megill
et al.13 calculated ESRD rates by dividing the total number of
cases of ESRD among Native Americans living on the Navajo
Reservation by the total population on the Navajo Nation.
Rather than using United States Renal Data System (USRDS)
data to determine the number of ESRD cases as we did,
however, Megill et al.13 used three data sources – the ESRD
Netwetwork 6 registry in Albuquerquee, Indian Health
Service records, and clinical records maintained by one of
the study authors. Also, rather than using Census Bureau
data to determine the population on the Navajo Nation as we
did, they used data provided by a tribal statistician and
demographer).
Much, but not all, of the disparity in rates of ESRD
between the Navajo community and the general US
population appears to be due to diabetes: we found that
the age-adjusted prevalence and incidence of ESRD asso-
ciated with diabetes were close to six times and 4.5 times
those among the general US population, respectively.
Similarly, the age-adjusted prevalence and incidence of ESRD
associated with diabetes were 1.7 times and 1.5 times that
among Native Americans in the US, respectively. These
findings are not surprising considering that the prevalence of
diabetes mellitus type II has been shown to be higher among
Navajos than in the general US population, as well as among
all Native Americans in the US.4–6 One study found that the
age-adjusted prevalence of medically diagnosed diabetes
mellitus type II among Navajo adults was approximately
15% in 1991–199214 (the most recent available data)
compared with about 3% in the general US population in
199214,15 and 11.5% among all Native Americans in the US in
1994.16
We also found that the prevalence of non-diabetic ESRD
was higher on the Navajo Nation compared with the general
US population and all Native Americans in the US: the age-
adjusted prevalence of ESRD not associated with diabetes was
close to two times that among both the general US
population and among Native Americans in the US. Based
on previous studies,9,17–21 the high rates of non-diabetic
kidney disease among Navajos may be attributable to very
high rates of glomerulonephritis, especially mesangial pro-
liferative glomerulonephritis, which has been found among
Southwest American Indian tribes, including the Navajo.18–21
Interestingly, however, we found that the age-adjusted
incidence of ESRD on the Navajo Nation not associated with
diabetes was not significantly different from that in the
general US population or among all Native Americans in the
US. It is possible that these rates were not significantly
different because of the small number of incident cases of
non-diabetic ESRD. However, the incidence of ESRD not
associated with diabetes was actually nonsignificantly lower
on the Navajo Nation compared with the incidence in the
general US population (0.19 vs 0.25%, Po0.20). The fact
that the prevalence, but not the incidence, of ESRD not
associated with diabetes was greatly increased on the Navajo
Nation compared with the general US population and all
Native Americans in the US may suggest that the incidence of
ESRD not associated with diabetes has decreased on the
Navajo Nation in recent years relative to that in these other
populations. Data from the USRDS indicate that the
incidence of non-diabetic ESRD increased by about 1.5-fold
between 1990 and 2001 among the general US population,
supporting this hypothesis. It is also possible, though
Table 3 | 2001 age-stratified incidence of ESRD among four groups X18 years of age: Native Americans on the Navajo Nation,
the General US Population, Native Americans in the US, and Native Americans in the Southwest excluding those on the Navajo
Nation
Population 18–24 (%) 25–34 (%) 35–44 (%) 45–64 (%) X65 (%)
Native Americans on the Navajo Nation 0.0074 0.017 0.028 0.15 0.31
General US population 0.0047 0.010 0.018 0.052 0.13
All Native Americans in the US 0.0049 0.014 0.029 0.097 0.20
Native Americans Living in AZ, NM, CO, and UT (excluding those on the Navajo Nation) 0.015 0.040 0.066 0.23 0.43
ESRD, end-stage renal disease.
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unlikely, that people with non-diabetic ESRD live longer with
the disease on the Navajo Nation than they do in the other
populations.
Although certain Southwest tribes such as the Zuni are
known to have extraordinarily high rates of kidney disease –
we did not expect that the rates of ESRD on the Navajo
Nation would approach the rates in the Zuni community –
we were surprised to discover that the rates of ESRD among
adults on the Navajo Nation were lower than the rates among
other Southwest Native American adults. Much of the
difference in ESRD rates between the Navajo Nation and
other Native Americans in the Southwest appears to relate to
diabetes: the prevalence and incidence of ESRD associated
with diabetes on the Navajo Nation were 41 and 36% lower
than among other Native American adults in the Southwest,
respectively.
In terms of non-diabetic kidney disease, the age-adjusted
prevalence was 1.3 times higher on the Navajo Nation
compared with that among other Southwest Native Ameri-
cans but the age-adjusted incidence was not significantly
different between these groups. Again, the lack of a difference
in incidence may be a statistical aberration due to the lower
number of incident cases of non-diabetic ESRD. However,
even though the difference did not reach statistical sig-
nificance, our study suggests that the incidence of non-
diabetic ESRD may be lower on the Navajo Nation than
among other Southwest Native Americans (0.019 vs 0.025%,
Po0.33). Unless Navajos live longer with ESRD than other
Native Americans in the Southwest, these findings suggest
that the incidence of non-diabetic ESRD among other Native
Americans of the Southwest may be rising relative to that on
the Navajo Nation.
Finally, we calculated the incidence of ESRD on the Navajo
Nation within several age groups and found that Navajo
adults over the age of 45 are especially vulnerable to ESRD.
For example, the incidence of ESRD was 1.5 times higher
among adults on the Navajo Nation under the age of 45
compared with adults under the age of 45 in the general US
population (Po0.19, note that this difference does not reach
statistical significance); however, the incidence of ESRD was
2.5 times higher among adults on the Navajo Nation over the
age of 45 compared with adults over the age of 45 in the
general US population (Po0.0001). More work is needed to
determine why this is the case.
Other factors besides the high rates of diabetes mellitus
may contribute to the high rates of ESRD among Navajo
adults. One such factor may be socioeconomic disparities
between the Navajo community and the general US
population as well as among all Native Americans in the
US. According to Census Bureau data from 2000, 37% of
Navajos live in poverty compared with 12% in the general US
population and 25.7% among all Native Americans in the
US.22 Additionally, average annual earnings among Navajos
are $10 000 per year lower than those of Americans in the
general population and $2,500 lower than those of all Native
Americans in the US.22 And in almost 25% of Navajo
households, English is spoken only poorly compared with
about 8% of total US households and about 10% of all Native
American households in the US.22 Although all Navajos are
eligible for health care at Indian Health Service facilities,
socioeconomic factors may interfere with the ability of
Navajo tribal members to access health care, which may
contribute to the high rates of kidney disease and kidney
disease risk factors such as diabetes and hypertension on the
Navajo Nation. For example, financial concerns may make
travel to health clinics more difficult, and language barriers
may complicate the management of chronic conditions like
diabetes and hypertension.
Socioeconomic disparities may also contribute to the
elevated rates of ESRD among Southwest American Indians
besides the Navajo. Per capita income is even lower among
several other Southwest American Indian tribes than it is on
the Navajo Nation. For example, per capita income is $6133
on the Gila River Reservation and $6976 on the Zuni Pueblo
compared with $7269 on the Navajo Nation.23
Additionally, previous studies have suggested that genetics
play an important role in the development of both
diabetic24,25 and non-diabetic kidney disease.26,27 A genetic
predisposition to kidney disease among the Navajo as well as
other American Indian tribes cannot be ruled out.
There are limitations to our study. First, because the
USRDS does not provide data broken down by tribe, we
determined the prevalence and incidence of ESRD among all
Native Americans living on or near the reservation, regardless
of tribal affiliation. This could cause an over- or under-
estimate of the prevalence and incidence among Navajos if
non-Navajo Native Americans living on or near the
reservation have much higher or lower rates of kidney
disease, respectively, than do Navajos. We do not believe that
this is likely to be a significant source of error because
approximately 90% of Native Americans living within the
Navajo Service Area are Navajo. Other indigenous groups
that live within the Navajo Service Area include Zuni,
Apache, Cherokee, Sioux, and Yuman Indians.28
Second, the zip codes used by the USRDS do not
correspond exactly to the Zip Code Tabulation Areas
(ZCTAs) used by the Census Bureau.29 We believe the impact
of this discrepancy is likely to be small. First, ZCTAs are
intended to correspond closely to zip codes. Second, people
living in a ZCTA who do not correspond to their zip code are
typically assigned to an adjacent ZCTA. Only along the
border of the study area might individuals be incorrectly
included or excluded from the population total. Third, we
cannot think of any reasons why geographic differences
between ZCTAs and zip codes would introduce a differential
bias.
A third potential limitation of this study is that we
calculated the number of cases of ESRD on the Navajo
Nation using 2001 ESRD data, the most recently available
validated data, however we used data from Census 2000 to
estimate the Navajo population. We did this because the
Census Bureau only reports data from major census years.
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Changes in the demographics of the Navajo population
between 2000 and 2001 may have lead to an error in the
results. However, it is unlikely that these changes would have
been large enough to have caused significant inaccuracies.
In conclusion, ESRD is much more common among
Native American adults living on or near the Navajo Nation
than in the general US population or among all Native
Americans in the US. Ongoing efforts to prevent diabetes
mellitus and its long-term complications are important to
reduce the disparate burden of morbidity, mortality, and
health care utilization from ESRD in this high-risk popula-
tion. In particular, initiatives like the National Diabetes
Education Program,30,31 jointly sponsored by the Centers for
Disease Control and Prevention and the National Institutes
of Health, as well as locally organized efforts, such as the
Healthy Path Nutrition and Physical Activity Program for
Navajo Elders,32 will be valuable for reducing the rates of
diabetic kidney disease.
More work is needed to understand why the prevalence
(but not the incidence) of non-diabetic ESRD is elevated
among Native American adults living on the Navajo Nation.
A first step might be to better characterize the types of non-
diabetic kidney disease from which Native Americans on the
Navajo reservation suffer. To this end, further studies like the
one conducted by Smith et al.21 in which clinical ESRD is
correlated with pathological diagnoses might be helpful. At
the same time, more work is needed to assess whether
socioeconomic, cultural, geographic, genetic, or other factors
may contribute to the elevated rates of non-diabetic kidney
disease in this population.
Finally, this study provides a new approach for calculating
rates of ESRD in relatively large geographic areas like the
Navajo reservation. To our knowledge, no previous authors
have used USRDS prevalence and incidence data to calculate
disease rates over geographic regions conforming to ZCTAs.
The approach we used would be applicable for determining
ESRD rates in other large geographic regions such as
metropolitan areas or other large Indian Reservations.
MATERIALS AND METHODS
Study population
The Navajo Nation is a 16 million acre area in Arizona, New Mexico,
and Utah with more than 200 000 inhabitants; it is one of the largest
federally recognized tribes in the US. Health care is provided to
Native Americans by the Indian Health Service. The Navajo Area of
the Indian Health Service, which serves the geographic region
approximating the Navajo Nation, includes 82 zip codes on or
adjacent to the Navajo Nation (see Figure 1). Approximately, 90% of
the Native Americans who live in these 82 zip codes identify
themselves as Navajo through ‘tribal affiliation or community
attachment’.28
Study design
We used the USRDS database to determine the number of Native
American adults X18 with ESRD who reside in one of the 82 zip
codes that are part of the Navajo Service Area.33 We used the same
database to determine the number of new, or incident, cases of
ESRD among Native American adultsX18 living within the Navajo
Service Area per year. Of note, the USRDS does not provide data on
individual tribal affiliation. We then determined how many of these
patients had ESRD associated with diabetes and how many were on




Figure 1 | Map of the Navajo Service Area.37 The blackened area represents the Navajo Reservation, which is approximately 16 million acres
in size. The Hopi Reservation, approximately 1.6 million acres in size, is the white area enclosed within the Navajo Reservation. The black line
surrounding the reservation demarcates the 82 zip codes that make up the ‘Navajo Service Area’ (see text for an explanation of the ‘Navajo
Service Area’). Zip codes located within Hopi territory are not part of the Navajo Service Area.
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2001, because this is the most recent year for which validated data
are available.
For the denominator in the prevalence and incidence calcula-
tions, we estimated the population of Native Americans living
within the Navajo Service Area using Census Bureau data from
Census 2000. The Census Bureau does not report data by zip codes,
but rather by ZCTAs, which are a close approximation of zip codes
that correspond to census-defined blocks of land rather than postal
service boundaries. A detailed description of ZTCAs can be found at
http://www.census.gov/geo/ZCTA/zctafaq.html. Using the Census
Bureau’s American FactFinder program, we determined the number
of Native Americans adults X18 who live in the 82 ZCTAs that
make up the Navajo Service Area.28
We estimated the crude prevalence and incidence of ESRD by
dividing the total number of Native American adults with ESRD
who live in the Navajo Service Area zip codes by the total number of
Native American adults who live in the Navajo Service Area ZCTAs.
The prevalence and incidence were age-adjusted to the 2000 US
population using the direct method34 using the age categories 18–24,
25–34, 35–44, 45–64, and X65.
For comparison, we calculated the 2001 crude and age-adjusted
prevalence and incidence of ESRD in a similar manner in the
general US adult population among Native American adults in the
US, and among Native American adults living in Arizona, New
Mexico, Utah, and Colorado excluding those living on the Navajo
Nation.35
We used two-tailed Z-tests to compare the age-adjusted
prevalence and incidence of ESRD on the Navajo Nation with those
calculated in each of the other populations.36 We used two-tailed
Z-tests to compare the age-stratified rates among the populations as
well.
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